| Aswani Kumar Suthrave, MD | |
|
3600 Joseph Siewick Dr, Fairfax, VA 22033-1709 | |
| (703) 391-3600 | |
| Not Available |
| Full Name | Aswani Kumar Suthrave |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 23 Years |
| Location | 3600 Joseph Siewick Dr, Fairfax, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013942341 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 229009 (Massachusetts) | Secondary |
| 208M00000X | Hospitalist | D0071306 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Western Maryland Regional Medical Center | Cumberland, MD | Hospital |
| Novant Health Uva Health System Culpeper Med Cente | Culpeper, VA | Hospital |
| Sentara Martha Jefferson Hospital | Charlottesville, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Usacs Integrated Acute Care Services Of Maryland Llc | 4486900172 | 218 |
| Uva Community Health Medical Group, Llc | 4688587967 | 198 |
News Archive
First generation cephalosporins—antibiotics introduced as a treatment against bacterial infections in 1963—now show promise for tuberculosis (TB) therapy, according to new research published in Scientific Reports.
Agendia, a commercial-stage molecular cancer diagnostics company, announces today that it has entered into a research collaboration with The University of Texas MD Anderson Cancer Center, one of the world's leading cancer centers and whose research program is considered one of the most productive in the world aimed solely at cancer, and the Netherlands Cancer Institute (NKI) with the aim of improving diagnosis and treatment options of colorectal cancer patients.
The New York Times Prescriptions Blog: "The question of equality, or inequality, among states is a major reason President Obama's overhaul of the health care system, and the legislation in Congress to make it happen, seemed to reach the brink of collapse last week." The issue also reflects "one of the biggest challenges" the President and Congressional leaders face in their efforts to overhaul the health care system. The key question: "how to devise a national solution for a problem that varies sharply from state to state."
Researchers at Mt. Sinai School of Medicine have developed a novel influenza vaccine that could represent the next step towards a universal influenza vaccine eliminating the need for seasonal immunizations. They report their findings today in the inaugural issue of mBio-, the first online, open-access journal published by the American Society for Microbiology.
› Verified 6 days ago
| Entity Name | Mgmc Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891797148 PECOS PAC ID: 9537073119 Enrollment ID: O20031118000305 |
News Archive
First generation cephalosporins—antibiotics introduced as a treatment against bacterial infections in 1963—now show promise for tuberculosis (TB) therapy, according to new research published in Scientific Reports.
Agendia, a commercial-stage molecular cancer diagnostics company, announces today that it has entered into a research collaboration with The University of Texas MD Anderson Cancer Center, one of the world's leading cancer centers and whose research program is considered one of the most productive in the world aimed solely at cancer, and the Netherlands Cancer Institute (NKI) with the aim of improving diagnosis and treatment options of colorectal cancer patients.
The New York Times Prescriptions Blog: "The question of equality, or inequality, among states is a major reason President Obama's overhaul of the health care system, and the legislation in Congress to make it happen, seemed to reach the brink of collapse last week." The issue also reflects "one of the biggest challenges" the President and Congressional leaders face in their efforts to overhaul the health care system. The key question: "how to devise a national solution for a problem that varies sharply from state to state."
Researchers at Mt. Sinai School of Medicine have developed a novel influenza vaccine that could represent the next step towards a universal influenza vaccine eliminating the need for seasonal immunizations. They report their findings today in the inaugural issue of mBio-, the first online, open-access journal published by the American Society for Microbiology.
› Verified 6 days ago
| Entity Name | Johns Hopkins University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922008549 PECOS PAC ID: 8921903147 Enrollment ID: O20031215000719 |
News Archive
First generation cephalosporins—antibiotics introduced as a treatment against bacterial infections in 1963—now show promise for tuberculosis (TB) therapy, according to new research published in Scientific Reports.
Agendia, a commercial-stage molecular cancer diagnostics company, announces today that it has entered into a research collaboration with The University of Texas MD Anderson Cancer Center, one of the world's leading cancer centers and whose research program is considered one of the most productive in the world aimed solely at cancer, and the Netherlands Cancer Institute (NKI) with the aim of improving diagnosis and treatment options of colorectal cancer patients.
The New York Times Prescriptions Blog: "The question of equality, or inequality, among states is a major reason President Obama's overhaul of the health care system, and the legislation in Congress to make it happen, seemed to reach the brink of collapse last week." The issue also reflects "one of the biggest challenges" the President and Congressional leaders face in their efforts to overhaul the health care system. The key question: "how to devise a national solution for a problem that varies sharply from state to state."
Researchers at Mt. Sinai School of Medicine have developed a novel influenza vaccine that could represent the next step towards a universal influenza vaccine eliminating the need for seasonal immunizations. They report their findings today in the inaugural issue of mBio-, the first online, open-access journal published by the American Society for Microbiology.
› Verified 6 days ago
| Entity Name | Hospitalist Medicine Physicians Of Maryland Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992945471 PECOS PAC ID: 8729138003 Enrollment ID: O20120223000194 |
News Archive
First generation cephalosporins—antibiotics introduced as a treatment against bacterial infections in 1963—now show promise for tuberculosis (TB) therapy, according to new research published in Scientific Reports.
Agendia, a commercial-stage molecular cancer diagnostics company, announces today that it has entered into a research collaboration with The University of Texas MD Anderson Cancer Center, one of the world's leading cancer centers and whose research program is considered one of the most productive in the world aimed solely at cancer, and the Netherlands Cancer Institute (NKI) with the aim of improving diagnosis and treatment options of colorectal cancer patients.
The New York Times Prescriptions Blog: "The question of equality, or inequality, among states is a major reason President Obama's overhaul of the health care system, and the legislation in Congress to make it happen, seemed to reach the brink of collapse last week." The issue also reflects "one of the biggest challenges" the President and Congressional leaders face in their efforts to overhaul the health care system. The key question: "how to devise a national solution for a problem that varies sharply from state to state."
Researchers at Mt. Sinai School of Medicine have developed a novel influenza vaccine that could represent the next step towards a universal influenza vaccine eliminating the need for seasonal immunizations. They report their findings today in the inaugural issue of mBio-, the first online, open-access journal published by the American Society for Microbiology.
› Verified 6 days ago
| Entity Name | Medstar Medical Group Ii Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184046187 PECOS PAC ID: 0547413825 Enrollment ID: O20130117000347 |
News Archive
First generation cephalosporins—antibiotics introduced as a treatment against bacterial infections in 1963—now show promise for tuberculosis (TB) therapy, according to new research published in Scientific Reports.
Agendia, a commercial-stage molecular cancer diagnostics company, announces today that it has entered into a research collaboration with The University of Texas MD Anderson Cancer Center, one of the world's leading cancer centers and whose research program is considered one of the most productive in the world aimed solely at cancer, and the Netherlands Cancer Institute (NKI) with the aim of improving diagnosis and treatment options of colorectal cancer patients.
The New York Times Prescriptions Blog: "The question of equality, or inequality, among states is a major reason President Obama's overhaul of the health care system, and the legislation in Congress to make it happen, seemed to reach the brink of collapse last week." The issue also reflects "one of the biggest challenges" the President and Congressional leaders face in their efforts to overhaul the health care system. The key question: "how to devise a national solution for a problem that varies sharply from state to state."
Researchers at Mt. Sinai School of Medicine have developed a novel influenza vaccine that could represent the next step towards a universal influenza vaccine eliminating the need for seasonal immunizations. They report their findings today in the inaugural issue of mBio-, the first online, open-access journal published by the American Society for Microbiology.
› Verified 6 days ago
| Entity Name | Johns Hopkins University |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1902332133 PECOS PAC ID: 4981745098 Enrollment ID: O20170818000085 |
News Archive
First generation cephalosporins—antibiotics introduced as a treatment against bacterial infections in 1963—now show promise for tuberculosis (TB) therapy, according to new research published in Scientific Reports.
Agendia, a commercial-stage molecular cancer diagnostics company, announces today that it has entered into a research collaboration with The University of Texas MD Anderson Cancer Center, one of the world's leading cancer centers and whose research program is considered one of the most productive in the world aimed solely at cancer, and the Netherlands Cancer Institute (NKI) with the aim of improving diagnosis and treatment options of colorectal cancer patients.
The New York Times Prescriptions Blog: "The question of equality, or inequality, among states is a major reason President Obama's overhaul of the health care system, and the legislation in Congress to make it happen, seemed to reach the brink of collapse last week." The issue also reflects "one of the biggest challenges" the President and Congressional leaders face in their efforts to overhaul the health care system. The key question: "how to devise a national solution for a problem that varies sharply from state to state."
Researchers at Mt. Sinai School of Medicine have developed a novel influenza vaccine that could represent the next step towards a universal influenza vaccine eliminating the need for seasonal immunizations. They report their findings today in the inaugural issue of mBio-, the first online, open-access journal published by the American Society for Microbiology.
› Verified 6 days ago
| Entity Name | Usacs Integrated Acute Care Services Of Maryland Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922598929 PECOS PAC ID: 4486900172 Enrollment ID: O20180711001232 |
News Archive
First generation cephalosporins—antibiotics introduced as a treatment against bacterial infections in 1963—now show promise for tuberculosis (TB) therapy, according to new research published in Scientific Reports.
Agendia, a commercial-stage molecular cancer diagnostics company, announces today that it has entered into a research collaboration with The University of Texas MD Anderson Cancer Center, one of the world's leading cancer centers and whose research program is considered one of the most productive in the world aimed solely at cancer, and the Netherlands Cancer Institute (NKI) with the aim of improving diagnosis and treatment options of colorectal cancer patients.
The New York Times Prescriptions Blog: "The question of equality, or inequality, among states is a major reason President Obama's overhaul of the health care system, and the legislation in Congress to make it happen, seemed to reach the brink of collapse last week." The issue also reflects "one of the biggest challenges" the President and Congressional leaders face in their efforts to overhaul the health care system. The key question: "how to devise a national solution for a problem that varies sharply from state to state."
Researchers at Mt. Sinai School of Medicine have developed a novel influenza vaccine that could represent the next step towards a universal influenza vaccine eliminating the need for seasonal immunizations. They report their findings today in the inaugural issue of mBio-, the first online, open-access journal published by the American Society for Microbiology.
› Verified 6 days ago
| Entity Name | Tidalhealth Specialty Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619504735 PECOS PAC ID: 7113340845 Enrollment ID: O20200714000286 |
News Archive
First generation cephalosporins—antibiotics introduced as a treatment against bacterial infections in 1963—now show promise for tuberculosis (TB) therapy, according to new research published in Scientific Reports.
Agendia, a commercial-stage molecular cancer diagnostics company, announces today that it has entered into a research collaboration with The University of Texas MD Anderson Cancer Center, one of the world's leading cancer centers and whose research program is considered one of the most productive in the world aimed solely at cancer, and the Netherlands Cancer Institute (NKI) with the aim of improving diagnosis and treatment options of colorectal cancer patients.
The New York Times Prescriptions Blog: "The question of equality, or inequality, among states is a major reason President Obama's overhaul of the health care system, and the legislation in Congress to make it happen, seemed to reach the brink of collapse last week." The issue also reflects "one of the biggest challenges" the President and Congressional leaders face in their efforts to overhaul the health care system. The key question: "how to devise a national solution for a problem that varies sharply from state to state."
Researchers at Mt. Sinai School of Medicine have developed a novel influenza vaccine that could represent the next step towards a universal influenza vaccine eliminating the need for seasonal immunizations. They report their findings today in the inaugural issue of mBio-, the first online, open-access journal published by the American Society for Microbiology.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Aswani Kumar Suthrave, MD 3600 Joseph Siewick Dr, Fairfax, VA 22033-1709 Ph: (703) 391-3600 | Aswani Kumar Suthrave, MD 3600 Joseph Siewick Dr, Fairfax, VA 22033-1709 Ph: (703) 391-3600 |
News Archive
First generation cephalosporins—antibiotics introduced as a treatment against bacterial infections in 1963—now show promise for tuberculosis (TB) therapy, according to new research published in Scientific Reports.
Agendia, a commercial-stage molecular cancer diagnostics company, announces today that it has entered into a research collaboration with The University of Texas MD Anderson Cancer Center, one of the world's leading cancer centers and whose research program is considered one of the most productive in the world aimed solely at cancer, and the Netherlands Cancer Institute (NKI) with the aim of improving diagnosis and treatment options of colorectal cancer patients.
The New York Times Prescriptions Blog: "The question of equality, or inequality, among states is a major reason President Obama's overhaul of the health care system, and the legislation in Congress to make it happen, seemed to reach the brink of collapse last week." The issue also reflects "one of the biggest challenges" the President and Congressional leaders face in their efforts to overhaul the health care system. The key question: "how to devise a national solution for a problem that varies sharply from state to state."
Researchers at Mt. Sinai School of Medicine have developed a novel influenza vaccine that could represent the next step towards a universal influenza vaccine eliminating the need for seasonal immunizations. They report their findings today in the inaugural issue of mBio-, the first online, open-access journal published by the American Society for Microbiology.
› Verified 6 days ago
Dr. Rinku Patel Jagait, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 3600 Joseph Siewick Dr, Fair Oaks Hospitalist Physicians Pllc, Fairfax, VA 22033 Phone: 703-391-3558 Fax: 703-391-3441 | |
Dr. Zaid Akram Hammoodi, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 8316 Arlington Blvd Ste 104, Fairfax, VA 22031 Phone: 703-560-1313 | |
Mitul Butala, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3600 Joseph Siewick Dr, Fairfax, VA 22033 Phone: 703-391-3600 Fax: 703-391-3414 |